Alembic Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) has conducted an inspection at the company's API facility located at Panelav from 17 December 2018 to 19 December 2018. This was a scheduled inspection and at the end of the inspection, there were ze...read more